Recent Finacing
Recent Raise
Rib-X Pharmaceuticals develops broad-spectrum antibiotics—delafloxacin (IV and oral), radezolid, and Rχ-04—using atomic-level ribosome modeling and 3‑D antibiotic design, advancing candidates through hospital-focused clinical trials.
Recent Investors
Total Raised
Funding rounds
Investors
